Welcome to our dedicated page for Kronos Worldwide news (Ticker: $KRO), a resource for investors and traders seeking the latest updates and insights on Kronos Worldwide stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Kronos Worldwide's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Kronos Worldwide's position in the market.
Kronos Worldwide, Inc. reported a net income of $8.1 million, or $.07 per share, in the first quarter of 2024, a significant improvement from a net loss of $15.2 million, or $.13 per share, in the first quarter of 2023. This positive result was driven by higher sales and production volumes, lower TiO2 selling prices, and decreased production costs. Net sales of $478.8 million in Q1 2024 were 12% higher than in Q1 2023, primarily due to stronger demand for TiO2 in major markets and increased sales volumes. TiO2 segment profit also saw a notable increase to $23.4 million in Q1 2024 from a loss of $14.8 million in Q1 2023. Overall, the company showed significant financial improvement in the first quarter of 2024 compared to the same period in 2023.